Advertisement
Screener

BRIACELL THERAPEUTICS CORP. (BCTX) Issued Capital

2.8 / 5 stars · 68/120 Roast Me

BRIACELL THERAPEUTICS CORP. Issued Capital

BRIACELL THERAPEUTICS CORP. (BCTX) had Issued Capital of $55.85 million as of 2022-04-30, per its 6-K filed 2022-06-13.

Discontinued › Notes

ifrs-full:IssuedCapital · last filed 2022-06-13

  • 2020-07-31: Issued Capital 15.07M CAD.
  • 2019-08-01: Issued Capital 13.65M CAD.

CAD

Period endIssued Capital
2020-07-3115.07M CAD
40-F/A · filed 2021-11-16
2019-08-0113.65M CAD
40-F/A · filed 2021-11-16

USD

Period endIssued Capital
2022-04-30$55.85M
6-K · filed 2022-06-13
2022-01-31$53.94M
6-K · filed 2022-03-15
2021-07-31$54.78M
6-K · filed 2022-06-13
2020-07-31$12.26M
40-F/A · filed 2021-11-16
2019-08-01$11.11M
40-F/A · filed 2021-11-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
PMGC Holdings Inc. (ELAB)United States$0.037B
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
Celularity Inc (CELU)United States$0.038B-0.34
CervoMed Inc. (CRVO)United States$0.038B-1.39
Edesa Biotech, Inc. (EDSA)Canada$0.039B
ROCKWELL MEDICAL, INC. (RMTI)United States$0.035B
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98